146 related articles for article (PubMed ID: 20150614)
1. Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139.
Weecharangsan W; Yu B; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
Anticancer Res; 2010 Jan; 30(1):31-7. PubMed ID: 20150614
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2.
Weecharangsan W; Lee RJ
Drug Deliv; 2012 Aug; 19(6):292-7. PubMed ID: 22931245
[TBL] [Abstract][Full Text] [Related]
3. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
4. Efficient delivery of antisense oligodeoxyribonucleotide g3139 by human serum albumin-coated liposomes.
Weecharangsan W; Yu B; Zheng Y; Liu S; Pang JX; Lee LJ; Marcucci G; Lee RJ
Mol Pharm; 2009; 6(6):1848-55. PubMed ID: 19725564
[TBL] [Abstract][Full Text] [Related]
5. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes.
Chiu SJ; Liu S; Perrotti D; Marcucci G; Lee RJ
J Control Release; 2006 May; 112(2):199-207. PubMed ID: 16564596
[TBL] [Abstract][Full Text] [Related]
6. Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
Hu Q; Bally MB; Madden TD
Nucleic Acids Res; 2002 Aug; 30(16):3632-41. PubMed ID: 12177306
[TBL] [Abstract][Full Text] [Related]
7. Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing.
Koh CG; Zhang X; Liu S; Golan S; Yu B; Yang X; Guan J; Jin Y; Talmon Y; Muthusamy N; Chan KK; Byrd JC; Lee RJ; Marcucci G; Lee LJ
J Control Release; 2010 Jan; 141(1):62-9. PubMed ID: 19716852
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes.
Weecharangsan W; Opanasopit P; Yingyongnarongkul BE; Kewsuwan P; Lee RJ
Curr Pharm Biotechnol; 2014; 15(9):790-9. PubMed ID: 25307014
[TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.
Yang X; Koh CG; Liu S; Pan X; Santhanam R; Yu B; Peng Y; Pang J; Golan S; Talmon Y; Jin Y; Muthusamy N; Byrd JC; Chan KK; Lee LJ; Marcucci G; Lee RJ
Mol Pharm; 2009; 6(1):221-30. PubMed ID: 19183107
[TBL] [Abstract][Full Text] [Related]
10. Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
Lopes de Menezes DE; Hudon N; McIntosh N; Mayer LD
Clin Cancer Res; 2000 Jul; 6(7):2891-902. PubMed ID: 10914739
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Inhibition of Human Carcinoma Cell Growth
Weecharangsan W; Opanasopit P; Niyomtham N; Yingyongnarongkul BE; Kewsuwan P; Lee RJ
Anticancer Res; 2017 Nov; 37(11):6335-6340. PubMed ID: 29061817
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.
Shi J; Yan WW; Qi XR; Maitani Y; Nagai T
Drug Deliv; 2005; 12(6):349-56. PubMed ID: 16253950
[TBL] [Abstract][Full Text] [Related]
14. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
[TBL] [Abstract][Full Text] [Related]
15. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.
Meyer O; Kirpotin D; Hong K; Sternberg B; Park JW; Woodle MC; Papahadjopoulos D
J Biol Chem; 1998 Jun; 273(25):15621-7. PubMed ID: 9624154
[TBL] [Abstract][Full Text] [Related]
16. Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.
Hu Q; Shew CR; Bally MB; Madden TD
Biochim Biophys Acta; 2001 Sep; 1514(1):1-13. PubMed ID: 11513800
[TBL] [Abstract][Full Text] [Related]
17. Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition.
Nakamura N; Hart DA; Frank CB; Marchuk LL; Shrive NG; Ota N; Taira K; Yoshikawa H; Kaneda Y
J Biochem; 2001 May; 129(5):755-9. PubMed ID: 11328598
[TBL] [Abstract][Full Text] [Related]
18. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.
Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN
Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520
[TBL] [Abstract][Full Text] [Related]
19. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
